Christopher S. Kearn

1.4k total citations
9 papers, 1.2k citations indexed

About

Christopher S. Kearn is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christopher S. Kearn has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christopher S. Kearn's work include Cannabis and Cannabinoid Research (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Christopher S. Kearn is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Christopher S. Kearn collaborates with scholars based in United States and New Zealand. Christopher S. Kearn's co-authors include Ken Mackie, Cecilia J. Hillard, Michelle Glass, Katherine G. Blake-Palmer, William B. Campbell, Tanya L. Daigle, Kasem Nithipatikom, Sandra L. Pfister, Erica J. Carrier and Andrew J. Barkmeier and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Comparative Neurology and FEBS Letters.

In The Last Decade

Christopher S. Kearn

9 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher S. Kearn United States	9	949	690	236	170	129	9	1.2k
Allyn Franklin United States	11	849 0.9×	571 0.8×	188 0.8×	263 1.5×	121 0.9×	11	1.3k
Abbas Jarrahian United States	9	1.1k 1.2×	722 1.0×	96 0.4×	211 1.2×	142 1.1×	10	1.2k
B. Emmanuel Akinshola United States	10	760 0.8×	636 0.9×	96 0.4×	180 1.1×	83 0.6×	16	900
Jian-Ping Gong China	6	623 0.7×	602 0.9×	218 0.9×	197 1.2×	85 0.7×	12	1.1k
Leyre Urigüen Spain	18	554 0.6×	572 0.8×	195 0.8×	100 0.6×	88 0.7×	42	996
M Rinaldi-Carmona France	13	1.6k 1.7×	1.2k 1.7×	299 1.3×	415 2.4×	232 1.8×	14	1.8k
Brian C. Shonesy United States	17	413 0.4×	564 0.8×	296 1.3×	210 1.2×	70 0.5×	20	1.0k
B.F. Cravatt United States	5	767 0.8×	454 0.7×	97 0.4×	218 1.3×	68 0.5×	6	867
Maoxing Shen United States	7	926 1.0×	853 1.2×	94 0.4×	318 1.9×	104 0.8×	8	1.1k
Mathilde Metna‐Laurent France	10	691 0.7×	649 0.9×	64 0.3×	289 1.7×	97 0.8×	10	937

Countries citing papers authored by Christopher S. Kearn

Since Specialization

Citations

This map shows the geographic impact of Christopher S. Kearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Kearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Kearn more than expected).

Fields of papers citing papers by Christopher S. Kearn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Kearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Kearn. The network helps show where Christopher S. Kearn may publish in the future.

Co-authorship network of co-authors of Christopher S. Kearn

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher S. Kearn. A scholar is included among the top collaborators of Christopher S. Kearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher S. Kearn. Christopher S. Kearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Chamley, Larry, A K Bhalla, Peter Stone, et al.. (2008). Nuclear Localisation of the Endocannabinoid Metabolizing Enzyme Fatty Acid Amide Hydrolase (FAAH) in Invasive Trophoblasts and an Association with Recurrent Miscarriage. Placenta. 29(11). 970–975. 26 indexed citations

Daigle, Tanya L., Christopher S. Kearn, & Ken Mackie. (2007). Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology. 54(1). 36–44. 129 indexed citations

Chan, Jane W., et al.. (2006). Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens. The Journal of Comparative Neurology. 495(3). 299–313. 99 indexed citations

Kearn, Christopher S., et al.. (2005). Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?. Molecular Pharmacology. 67(5). 1697–1704. 284 indexed citations

Carrier, Erica J., Christopher S. Kearn, Andrew J. Barkmeier, et al.. (2004). Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism. Molecular Pharmacology. 65(4). 999–1007. 282 indexed citations

Helliwell, Rachel J. A., Larry Chamley, Katherine G. Blake-Palmer, et al.. (2004). Characterization of the Endocannabinoid System in Early Human Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 89(10). 5168–5174. 70 indexed citations

Hillard, Cecilia J., Shanmugam Muthian, & Christopher S. Kearn. (1999). Effects of CB₁ cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity. FEBS Letters. 459(2). 277–281. 79 indexed citations

Kearn, Christopher S., et al.. (1999). Relationships Between Ligand Affinities for the Cerebellar Cannabinoid Receptor CB1 and the Induction of GDP/GTP Exchange. Journal of Neurochemistry. 72(6). 2379–2387. 94 indexed citations

Edgemond, William S., Cecilia J. Hillard, John R. Falck, Christopher S. Kearn, & William B. Campbell. (1998). Human Platelets and Polymorphonuclear Leukocytes Synthesize Oxygenated Derivatives of Arachidonylethanolamide (Anandamide): Their Affinities for Cannabinoid Receptors and Pathways of Inactivation. Molecular Pharmacology. 54(1). 180–188. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact